These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 25860109)

  • 1. An integrated network of microRNA and gene expression in ovarian cancer.
    Quitadamo A; Tian L; Hall B; Shi X
    BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S5. PubMed ID: 25860109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
    Zhang J; Le TD; Liu L; He J; Li J
    Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-microRNA network module analysis for ovarian cancer.
    Zhang S; Ng MK
    BMC Syst Biol; 2016 Dec; 10(Suppl 4):117. PubMed ID: 28155675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling microRNA-mRNA interactions using PLS regression in human colon cancer.
    Li X; Gill R; Cooper NG; Yoo JK; Datta S
    BMC Med Genomics; 2011 May; 4():44. PubMed ID: 21595958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
    Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network.
    Wang X; Han L; Zhou L; Wang L; Zhang LM
    Oncol Rep; 2018 Nov; 40(5):2659-2673. PubMed ID: 30226545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of dysregulated miRNAs-genes network in ovarian cancer: An integrative approach to uncover the molecular interactions and oncomechanisms.
    Kadkhoda S; Darbeheshti F; Tavakkoly-Bazzaz J
    Cancer Rep (Hoboken); 2020 Dec; 3(6):e1286. PubMed ID: 32886452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated microRNA and mRNA signatures in peripheral blood lymphocytes of familial epithelial ovarian cancer.
    Dou YD; Huang T; Wang Q; Shu X; Zhao SG; Li L; Liu T; Lu G; Chan WY; Liu HB
    Biochem Biophys Res Commun; 2018 Jan; 496(1):191-198. PubMed ID: 29307835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
    Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer.
    Bai Y; Ding L; Baker S; Bai JM; Rath E; Jiang F; Wu J; Jiang H; Stuart G
    BMC Bioinformatics; 2016 Oct; 17(Suppl 13):336. PubMed ID: 27766936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel miRNA-target gene regulatory network in osteosarcoma by integrating transcriptome analysis.
    He C; Gao H; Fan X; Wang M; Liu W; Huang W; Yang Y
    Int J Clin Exp Pathol; 2015; 8(7):8348-57. PubMed ID: 26339404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma.
    Creighton CJ; Hernandez-Herrera A; Jacobsen A; Levine DA; Mankoo P; Schultz N; Du Y; Zhang Y; Larsson E; Sheridan R; Xiao W; Spellman PT; Getz G; Wheeler DA; Perou CM; Gibbs RA; Sander C; Hayes DN; Gunaratne PH;
    PLoS One; 2012; 7(3):e34546. PubMed ID: 22479643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crucial microRNAs and genes of human primary breast cancer explored by microRNA-mRNA integrated analysis.
    Yang Y; Xing Y; Liang C; Hu L; Xu F; Chen Y
    Tumour Biol; 2015 Jul; 36(7):5571-9. PubMed ID: 25680412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory network reconstruction of five essential microRNAs for survival analysis in breast cancer by integrating miRNA and mRNA expression datasets.
    He K; Li WX; Guan D; Gong M; Ye S; Fang Z; Huang JF; Lu A
    Funct Integr Genomics; 2019 Jul; 19(4):645-658. PubMed ID: 30859354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of miRNA-mRNA crosstalk in pancreatic cancer by integrating transcriptome analysis.
    Yang J; Zeng Y
    Eur Rev Med Pharmacol Sci; 2015; 19(5):825-34. PubMed ID: 25807437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The modularity and dynamicity of miRNA-mRNA interactions in high-grade serous ovarian carcinomas and the prognostic implication.
    Zhang W; Edwards A; Fan W; Flemington EK; Zhang K
    Comput Biol Chem; 2016 Aug; 63():3-14. PubMed ID: 26949157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
    Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma.
    Dong H; Luo L; Hong S; Siu H; Xiao Y; Jin L; Chen R; Xiong M
    BMC Syst Biol; 2010 Nov; 4():163. PubMed ID: 21114830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analyses to reconstruct microRNA-mediated regulatory networks in mouse liver using high-throughput profiling.
    Hsu SD; Huang HY; Chou CH; Sun YM; Hsu MT; Tsou AP
    BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S12. PubMed ID: 25707768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.